Why the West in West Nile virus infections?

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 18, Issue 5, 2007, Pages 285-288

  Conly, J M ^a   Johnston, B L ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; RIBAVIRIN;

CLIMATE; CLINICAL FEATURE; DISEASE TRANSMISSION; HUMAN; INCIDENCE; INFECTION PREVENTION; NONHUMAN; SHORT SURVEY; SYMPTOMATOLOGY; SYNDROME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

EID: 36749008481     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/704157     Document Type: Short Survey

References (36)

1. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940;20:471-92.
2. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002;2:519-29.
3. Centers for Disease Control and Prevention (CDC). Update: West Nile Virus activity - Eastern United States, 2000. MMWR Morb Mortal Wkly Rep 2000;49:1044-7. (Erratum in 2001;50:100-1).
4. Roehrig JT, Layton M, Smith P, Campbell GL, Nasci R, Lanciotti RS. The emergence of West Nile virus in North America: Ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol 2002;267:223-40.
5. Pealer LN, Marfin AA, Petersen LR, et al; West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
6. Centers for Disease Control and Prevention (CDC). Statistics, surveillance, and control: 2003 West Nile virus activity in the United States. 〈http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03. htm〉 (Version current at September 27, 2007).
7. Centers for Disease Control and Prevention (CDC). Update: Detection of West Nile virus in blood donations - United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:916-9. (Erratum in 2003;52:942).
8. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003;168:1399-405.
9. Public Health Agency of Canada. West Nile Virus MONITOR: 2007 Human Surveillance. 〈http://www.phac-aspc.gc.ca/wnv-vwn/mon-hmnsurv_e.html〉 (Version current at September 27, 2007).
10. Calisher CH, Karabatsos N, Dalrymple JM, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989;70:37-43.
11. Turell MJ, Sardelis MR, O'Guinn ML, Dohm DJ. Potential vectors of West Nile virus in North America. Curr Top Microbiol Immunol 2002;267:241-52.
12. Bender K, Thompson FE Jr. West Nile virus: A growing challenge. Am J Nurs 2003;103:32-40.
13. Solomon T, Ooi MH, Beasley DW, Maltewa M. West Nile encephalitis. BMJ 2003;326:865-9.
14. Centers for Disease Control and Prevention (CDC). Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep 2002;51:1135-6.
15. Centers for Disease Control and Prevention (CDC). Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002;51:877-8.
16. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from a donor to four transplant recipients. N Engl J Med 2003;348:2196-203.
17. Centers for Disease Control and Prevention (CDC). West Nile virus infection in organ donor and transplant recipients - Georgia and Florida, 2002. MMWR Morb Mortal Wkly Rep 2002;51:790.
18. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet 2001;358:261-4.
19. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003;290:511-5. (Erratum in 2003;290:1318).
20. Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003;9:788-93.
21. Burton JM, Kern RZ, Halliday W, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci 2004;31:185-93.
22. Marfin AA, Gubler DJ. West Nile encephalitis: An emerging disease in the United States. Clin Infect Dis 2001;33:1713-9.
23. Centers for Disease Control and Prevention. Encephalitis or meningitis, arboviral (includes California serogroup, Eastern equine, St Louis, Western equine, West Nile, Powassan): 2001 case definition 〈http://www.cdc.gov/epo/ dphsi/casedef/encephalitiscurrent.htm〉 (Version current at September 27, 2007).
24. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA 2003;290:524-8.
25. Klee AL, Maidin B, Edwin B, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004;10:1405-11.
26. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002;267:171-94.
27. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002;8:107-8.
28. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675-8.
29. Kalil AC, Devetten MP, Singh S, et al. Use of interferon-alpha in patients with West Nile encephalitis: Report of 2 cases. Clin Infect Dis 2005;40:764.
30. Chan-Tack KM, Forrest G. Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis. Scand J Infect Dis 2005;37:944-6.
31. Hamdan A, Green P, Mendelson E, Kramer MR, Pitlik S, Weinberger M. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 2002;4:160-2.
32. Curry P. Saskatchewan mosquitoes and West Nile virus. 〈http://wildlife1.usask.ca/wildlife_health_topics/arbovirus/ WNV%20and%20mosquitoes%20in%20SK%20P%20Curry%20Blue%20Jay%20June%2004.pdf〉 (Version current at September 27, 2007).
33. Turell MJ, O'Guinn ML, Dohm DJ, Jones JW. Vector competence of North American mosquitoes (Diptera: Culicidae) for West Nile virus. J Med Entomol 2001;38:130-4.
34. Goddard LB, Roth AE, Reisen WK, Scott TW. Vector competence of California mosquitoes for West Nile virus. Emerg Infect Dis 2002;8:1385-91. (Erratum in 2003;9:406).
35. Alberta Health and Wellness. West Nile Virus Surveillance Report - summary: Week 37. 〈http://www.health.gov.ab.ca/public/wnv_evidence. htm〉 (Version current at September 27, 2007).
36. Government of Saskatchewan. 2007 West Nile Virus Surveillance Results. 〈http://www.health.gov.sk.ca/wnv-surveillance-results〉 (Version current at September 27, 2007).